论文部分内容阅读
手术加腹腔内温热灌注(IPHP)化疗是一项联合治疗中晚期胃肠道癌的新技术,广西医科大学第一附属医院副教授陈利生和广西医科大学副校长、教授高枫博士等组成的研究课题组,自1992年开始,对此项新技术进行系列性研究。他们根据肿瘤生物新的特性、肿瘤组织血管和药物动力学的特点,在肿瘤根治切除或姑息手术后,通过自行研制的加温灌流驱动装置(加温灌注抗癌机),将加温43～45℃的化疗药溶液连续灌注入患者腹腔,时间一小时。即把手术、热疗和化疗三者结合一体并用,一次完成多种治疗,达到杀灭已播散、种植腹腔
Surgery plus intraperitoneal hyperthermic perfusion (IPHP) chemotherapy is a new technology for the treatment of advanced gastrointestinal cancer. Chen Lisheng, associate professor of the First Affiliated Hospital of Guangxi Medical University and Dr. Gao Feng, vice president and professor of Guangxi Medical University The research group, starting in 1992, conducted a series of studies on this new technology. Based on the new characteristics of tumor biology, the characteristics of tumor tissue vessels and pharmacokinetics, they will warm up through a self-developed warming perfusion drive device (warming perfusion anticancer machine) after radical resection or palliative surgery. The 45°C chemotherapeutic solution was continuously infused into the abdominal cavity of the patient for an hour. In other words, surgery, hyperthermia, and chemotherapy are combined and used together to complete multiple treatments at one time.